PANW Q1 2026 Earnings Strong EPS Beat Offsets Revenue Concerns MGRX Q3 2025 Earnings EPS Surprises with 069 Loss as Revenue Remains Undisclosed CRS Q1 2026 Earnings EPS Exceeds Expectations Amid Cautious Market Response IGC Pharma Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Lower AA Q1 2026 Earnings EPS Misses Estimates Shares Climb on Strategic Optimism INOD Q1 2026 Earnings Massive EPS Beat Drives Investor Skepticism